Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Pouw

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Seminars in Immunopathology|October 26, 2021
Tipping the balance: intricate roles of the complement system in disease and therapyRichard B Pouw, Daniel Ricklin
British Journal of Pharmacology|November 3, 2020
Sweet turning bitter: Carbohydrate sensing of complement in host defence and diseaseRachel Hevey, Richard B Pouw, Claire Harris, et al.
Frontiers in Immunology|July 28, 2018
Self-Damage Caused by Dysregulation of the Complement Alternative Pathway: Relevance of the Factor H Protein FamilyPilar Sánchez-Corral, Richard B Pouw, Margarita López-Trascasa, et al.
Molecular Immunology|August 20, 2018
Developments in anti-complement therapy; from disease to clinical trialClaire L Harris, Richard B Pouw, David Kavanagh, et al.
Frontiers in Immunology|May 3, 2018
Complement Factor H-Related Protein 4A Is the Dominant Circulating Splice Variant of <i>CFHR4</i>Richard B Pouw, Mieke C Brouwer, Anna E van Beek, et al.
Frontiers in Immunology|February 11, 2020
Corrigendum: High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele <i>CFHR3</i> <sup>*</sup> <i>B</i>Richard B Pouw, Irene Gómez Delgado, Alberto López Lera, et al.
Frontiers in Immunology|May 10, 2018
High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele <i>CFHR3*B</i>Richard B Pouw, Irene Gómez Delgado, Alberto López Lera, et al.
European Journal of Immunology|November 1, 2014
TFPI inhibits lectin pathway of complement activation by direct interaction with MASP-2Mischa P Keizer, Richard B Pouw, Angela M Kamp, et al.
Plos One|March 24, 2016
Complement Factor H-Related Protein 3 Serum Levels Are Low Compared to Factor H and Mainly Determined by Gene Copy Number Variation in CFHR3Richard B Pouw, Mieke C Brouwer, Judy Geissler, et al.
Frontiers in Immunology|November 27, 2024
Praziquantel and factor H recruitment differentially affect the susceptibility of <i>Schistosoma mansoni</i> to complement-mediated damageAnna E van Beek, Hannah Jeanguenat, Cécile Häberli, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Seminars in Immunopathology|October 26, 2021
Tipping the balance: intricate roles of the complement system in disease and therapyRichard B Pouw, Daniel Ricklin
British Journal of Pharmacology|November 3, 2020
Sweet turning bitter: Carbohydrate sensing of complement in host defence and diseaseRachel Hevey, Richard B Pouw, Claire Harris, et al.
Frontiers in Immunology|July 28, 2018
Self-Damage Caused by Dysregulation of the Complement Alternative Pathway: Relevance of the Factor H Protein FamilyPilar Sánchez-Corral, Richard B Pouw, Margarita López-Trascasa, et al.
Molecular Immunology|August 20, 2018
Developments in anti-complement therapy; from disease to clinical trialClaire L Harris, Richard B Pouw, David Kavanagh, et al.
Frontiers in Immunology|May 3, 2018
Complement Factor H-Related Protein 4A Is the Dominant Circulating Splice Variant of <i>CFHR4</i>Richard B Pouw, Mieke C Brouwer, Anna E van Beek, et al.
Frontiers in Immunology|February 11, 2020
Corrigendum: High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele <i>CFHR3</i> <sup>*</sup> <i>B</i>Richard B Pouw, Irene Gómez Delgado, Alberto López Lera, et al.
Frontiers in Immunology|May 10, 2018
High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele <i>CFHR3*B</i>Richard B Pouw, Irene Gómez Delgado, Alberto López Lera, et al.
European Journal of Immunology|November 1, 2014
TFPI inhibits lectin pathway of complement activation by direct interaction with MASP-2Mischa P Keizer, Richard B Pouw, Angela M Kamp, et al.
Plos One|March 24, 2016
Complement Factor H-Related Protein 3 Serum Levels Are Low Compared to Factor H and Mainly Determined by Gene Copy Number Variation in CFHR3Richard B Pouw, Mieke C Brouwer, Judy Geissler, et al.
Frontiers in Immunology|November 27, 2024
Praziquantel and factor H recruitment differentially affect the susceptibility of <i>Schistosoma mansoni</i> to complement-mediated damageAnna E van Beek, Hannah Jeanguenat, Cécile Häberli, et al.
Pageof 3